Eligibility Acute Leukemia NCT01036009

Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
age 6 months - 25 years.
Descripción

Age

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0001779
diagnoses of acute leukemia (aml, all, biphenotypic leukemia), pre-leukemic syndromes (monosomy 7 or other bone marrow clonal malformations), jmml, myelodysplastic syndromes or cml.
Descripción

diagnoses of acute leukemia

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0023418
undergoing an allogeneic transplant as standard care.
Descripción

undergoing an allogeneic transplant as standard care

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0149615
performance status: karnofsky/lansky>60%.
Descripción

performance status

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0206065
availability of pre-transplant recipient's dna and donor's dna for chimerism testing. this could be dna or material from which dna could be extracted. frozen blood would be preferred. for some patients, post transplant specimens that are not infiltrated with donor cells may be used.
Descripción

chimerism testing

Tipo de datos

boolean

Alias
UMLS CUI [1]
C3250865
bone marrow or pbmtc as stem cell source.hla matching: donor and recipient should be matched at a minimum of 7/8 antigens (a,b,c and drb1) for bone marrow and pbmtc transplants.
Descripción

bone marrow or pbmtc as stem cell source.hla matching: donor and recipient should be matched at a minimum of 7/8 antigens (a,b,c and drb1) for bone marrow and pbmtc transplants

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0005953
UMLS CUI [2]
C0038250
no history of ≥grade iii acute gvhd.
Descripción

no history of ≥grade iii acute gvhd

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0856825
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
treatment on other experimental protocols, if withdrawal of immunosuppression interferes with procedures of follow-up on the primary study.
Descripción

study subject participation status

Tipo de datos

boolean

Alias
UMLS CUI [1]
C2348568
leukemia relapse defined as > 5 percent blasts on bone marrow exam or >1 percent leukemia cells by immunoflow mrd, or presence of extramedullary leukemia.
Descripción

leukemia relapse

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0920028
history of acute gvhd ≥ stage iii or with any degree of active acute or cgvhd.
Descripción

acute gvhd

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0856825
on steroids for any reason.
Descripción

steroid treatment

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0149783
any condition that compromises compliance with the objectives and procedures of this protocol, as judged by the principal investigator.
Descripción

any condition that compromises compliance with the objectives and procedures of this protocol, as judged by the principal investigator.

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1321605
UMLS CUI [2]
C0439801
UMLS CUI [3]
C0009488
cells for dli cannot be obtained from the donor.
Descripción

cells for dli cannot be obtained from the donor

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1142167

Similar models

Eligibility Acute Leukemia NCT01036009

Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
Age
Item
age 6 months - 25 years.
boolean
C0001779 (UMLS CUI [1])
diagnoses of acute leukemia
Item
diagnoses of acute leukemia (aml, all, biphenotypic leukemia), pre-leukemic syndromes (monosomy 7 or other bone marrow clonal malformations), jmml, myelodysplastic syndromes or cml.
boolean
C0023418 (UMLS CUI [1])
undergoing an allogeneic transplant as standard care
Item
undergoing an allogeneic transplant as standard care.
boolean
C0149615 (UMLS CUI [1])
performance status
Item
performance status: karnofsky/lansky>60%.
boolean
C0206065 (UMLS CUI [1])
chimerism testing
Item
availability of pre-transplant recipient's dna and donor's dna for chimerism testing. this could be dna or material from which dna could be extracted. frozen blood would be preferred. for some patients, post transplant specimens that are not infiltrated with donor cells may be used.
boolean
C3250865 (UMLS CUI [1])
bone marrow or pbmtc as stem cell source.hla matching: donor and recipient should be matched at a minimum of 7/8 antigens (a,b,c and drb1) for bone marrow and pbmtc transplants
Item
bone marrow or pbmtc as stem cell source.hla matching: donor and recipient should be matched at a minimum of 7/8 antigens (a,b,c and drb1) for bone marrow and pbmtc transplants.
boolean
C0005953 (UMLS CUI [1])
C0038250 (UMLS CUI [2])
no history of ≥grade iii acute gvhd
Item
no history of ≥grade iii acute gvhd.
boolean
C0856825 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
study subject participation status
Item
treatment on other experimental protocols, if withdrawal of immunosuppression interferes with procedures of follow-up on the primary study.
boolean
C2348568 (UMLS CUI [1])
leukemia relapse
Item
leukemia relapse defined as > 5 percent blasts on bone marrow exam or >1 percent leukemia cells by immunoflow mrd, or presence of extramedullary leukemia.
boolean
C0920028 (UMLS CUI [1])
acute gvhd
Item
history of acute gvhd ≥ stage iii or with any degree of active acute or cgvhd.
boolean
C0856825 (UMLS CUI [1])
steroid treatment
Item
on steroids for any reason.
boolean
C0149783 (UMLS CUI [1])
any condition that compromises compliance with the objectives and procedures of this protocol, as judged by the principal investigator.
Item
any condition that compromises compliance with the objectives and procedures of this protocol, as judged by the principal investigator.
boolean
C1321605 (UMLS CUI [1])
C0439801 (UMLS CUI [2])
C0009488 (UMLS CUI [3])
cells for dli cannot be obtained from the donor
Item
cells for dli cannot be obtained from the donor.
boolean
C1142167 (UMLS CUI [1])